Cargando…
Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study
BACKGROUND: Low-dose aspirin is widely used for the prevention of cardiovascular events. The prevalence of gastroduodenal injuries and the risk factor profile including gastroprotective drug therapy needs to be clarified in Japanese patients taking daily aspirin for cardioprotection. METHODS: This M...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019829/ https://www.ncbi.nlm.nih.gov/pubmed/23754512 http://dx.doi.org/10.1007/s00535-013-0839-5 |
_version_ | 1782480217968738304 |
---|---|
author | Uemura, Naomi Sugano, Kentaro Hiraishi, Hideyuki Shimada, Kazuyuki Goto, Shinya Uchiyama, Shinichiro Okada, Yasushi Origasa, Hideki Ikeda, Yasuo |
author_facet | Uemura, Naomi Sugano, Kentaro Hiraishi, Hideyuki Shimada, Kazuyuki Goto, Shinya Uchiyama, Shinichiro Okada, Yasushi Origasa, Hideki Ikeda, Yasuo |
author_sort | Uemura, Naomi |
collection | PubMed |
description | BACKGROUND: Low-dose aspirin is widely used for the prevention of cardiovascular events. The prevalence of gastroduodenal injuries and the risk factor profile including gastroprotective drug therapy needs to be clarified in Japanese patients taking daily aspirin for cardioprotection. METHODS: This Management of Aspirin-induced Gastro-Intestinal Complications (MAGIC) study was conducted with a prospective nationwide, multicenter, real-world registry of Japanese patients at high-risk of cardiovascular diseases who were taking regular aspirin (75–325 mg) for 1 month or more. All patients underwent endoscopic examination for detection of gastroduodenal ulcer and mucosal erosion. The risk factor profiles including the concurrent drug therapy were compared for those patients with gastroduodenal problems and those without. RESULTS: Gastroduodenal ulcer and erosion were detected in 6.5, and 29.2 % of the 1,454 patients receiving aspirin, respectively. H. pylori infection was associated with an increased risk for ulcer: OR 1.83 (1.18–2.88 p = 0.0082). Risk of erosion was lower with enteric-coated aspirin than with buffered aspirin: odds ratio (OR) 0.47 (0.32–0.70, p = 0.0002). Patients receiving proton pump inhibitors had lower risks for both gastroduodenal ulcer and erosion: OR 0.34 (0.15–0.68, p = 0.0050) and 0.32 (0.22–0.46, p < 0.0001), respectively. However, those receiving histamine 2-receptor antagonists had reduced risks for erosion but not for ulcer: OR 0.49 (0.36–0.68, p < 0.0001). CONCLUSION: Gastroduodenal ulcer and erosion are common in Japanese patients taking low dose aspirin for cardioprotection. Proton pump inhibitors reduce the risk of gastroduodenal mucosal injury. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00535-013-0839-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4019829 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer Japan |
record_format | MEDLINE/PubMed |
spelling | pubmed-40198292014-05-14 Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study Uemura, Naomi Sugano, Kentaro Hiraishi, Hideyuki Shimada, Kazuyuki Goto, Shinya Uchiyama, Shinichiro Okada, Yasushi Origasa, Hideki Ikeda, Yasuo J Gastroenterol Original Article—Alimentary Tract BACKGROUND: Low-dose aspirin is widely used for the prevention of cardiovascular events. The prevalence of gastroduodenal injuries and the risk factor profile including gastroprotective drug therapy needs to be clarified in Japanese patients taking daily aspirin for cardioprotection. METHODS: This Management of Aspirin-induced Gastro-Intestinal Complications (MAGIC) study was conducted with a prospective nationwide, multicenter, real-world registry of Japanese patients at high-risk of cardiovascular diseases who were taking regular aspirin (75–325 mg) for 1 month or more. All patients underwent endoscopic examination for detection of gastroduodenal ulcer and mucosal erosion. The risk factor profiles including the concurrent drug therapy were compared for those patients with gastroduodenal problems and those without. RESULTS: Gastroduodenal ulcer and erosion were detected in 6.5, and 29.2 % of the 1,454 patients receiving aspirin, respectively. H. pylori infection was associated with an increased risk for ulcer: OR 1.83 (1.18–2.88 p = 0.0082). Risk of erosion was lower with enteric-coated aspirin than with buffered aspirin: odds ratio (OR) 0.47 (0.32–0.70, p = 0.0002). Patients receiving proton pump inhibitors had lower risks for both gastroduodenal ulcer and erosion: OR 0.34 (0.15–0.68, p = 0.0050) and 0.32 (0.22–0.46, p < 0.0001), respectively. However, those receiving histamine 2-receptor antagonists had reduced risks for erosion but not for ulcer: OR 0.49 (0.36–0.68, p < 0.0001). CONCLUSION: Gastroduodenal ulcer and erosion are common in Japanese patients taking low dose aspirin for cardioprotection. Proton pump inhibitors reduce the risk of gastroduodenal mucosal injury. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00535-013-0839-5) contains supplementary material, which is available to authorized users. Springer Japan 2013-06-12 2014 /pmc/articles/PMC4019829/ /pubmed/23754512 http://dx.doi.org/10.1007/s00535-013-0839-5 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by-nc/2.5/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Original Article—Alimentary Tract Uemura, Naomi Sugano, Kentaro Hiraishi, Hideyuki Shimada, Kazuyuki Goto, Shinya Uchiyama, Shinichiro Okada, Yasushi Origasa, Hideki Ikeda, Yasuo Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study |
title | Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study |
title_full | Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study |
title_fullStr | Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study |
title_full_unstemmed | Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study |
title_short | Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study |
title_sort | risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular japanese patients: the results from the magic study |
topic | Original Article—Alimentary Tract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019829/ https://www.ncbi.nlm.nih.gov/pubmed/23754512 http://dx.doi.org/10.1007/s00535-013-0839-5 |
work_keys_str_mv | AT uemuranaomi riskfactorprofilesdrugusageandprevalenceofaspirinassociatedgastroduodenalinjuriesamonghighriskcardiovascularjapanesepatientstheresultsfromthemagicstudy AT suganokentaro riskfactorprofilesdrugusageandprevalenceofaspirinassociatedgastroduodenalinjuriesamonghighriskcardiovascularjapanesepatientstheresultsfromthemagicstudy AT hiraishihideyuki riskfactorprofilesdrugusageandprevalenceofaspirinassociatedgastroduodenalinjuriesamonghighriskcardiovascularjapanesepatientstheresultsfromthemagicstudy AT shimadakazuyuki riskfactorprofilesdrugusageandprevalenceofaspirinassociatedgastroduodenalinjuriesamonghighriskcardiovascularjapanesepatientstheresultsfromthemagicstudy AT gotoshinya riskfactorprofilesdrugusageandprevalenceofaspirinassociatedgastroduodenalinjuriesamonghighriskcardiovascularjapanesepatientstheresultsfromthemagicstudy AT uchiyamashinichiro riskfactorprofilesdrugusageandprevalenceofaspirinassociatedgastroduodenalinjuriesamonghighriskcardiovascularjapanesepatientstheresultsfromthemagicstudy AT okadayasushi riskfactorprofilesdrugusageandprevalenceofaspirinassociatedgastroduodenalinjuriesamonghighriskcardiovascularjapanesepatientstheresultsfromthemagicstudy AT origasahideki riskfactorprofilesdrugusageandprevalenceofaspirinassociatedgastroduodenalinjuriesamonghighriskcardiovascularjapanesepatientstheresultsfromthemagicstudy AT ikedayasuo riskfactorprofilesdrugusageandprevalenceofaspirinassociatedgastroduodenalinjuriesamonghighriskcardiovascularjapanesepatientstheresultsfromthemagicstudy AT riskfactorprofilesdrugusageandprevalenceofaspirinassociatedgastroduodenalinjuriesamonghighriskcardiovascularjapanesepatientstheresultsfromthemagicstudy |